Diagnosing metabolic syndrome in type 2 diabetes: does it matter?

Background: Metabolic syndrome (MetS) is used as a clinical tool to identify individuals at risk of cardiovascular disease (CVD) but its clinical value in the management of type 2 diabetes mellitus (T2DM) remains uncertain. Aim: To determine the prevalence and clinical usefulness of MetS among patients with T2DM attending diabetes clinics in a large teaching hospital. Design: Prospective observational study. Methods: Prevalence of MetS was determined by using International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) definitions in relation to age, sex, diabetes duration and history of CVD. Results: A total of 390 patients were included in this study. Both IDF and NCEP-ATPIII definitions identified high prevalence of MetS in male and female patients (IDF: male vs. female, 91.7 vs. 94.8% and NCEP-ATPIII: male vs. female, 87.6 vs. 94.2%) regardless of age (below vs. above 40 yrs, âˆ¼70â€“75 vs. âˆ¼90â€“95% with both definitions), diabetes duration (below vs. above 5 yrs, âˆ¼85â€“90 vs. 90â€“95% with both definitions) and history of CVD (without vs. with CVD, âˆ¼90 vs. âˆ¼95% with both definitions). Central obesity was common reflected by mean waist circumference of âˆ¼113 cm regardless of age and gender. Among those who did not have IDF-defined MetS, âˆ¼60% had at least two CVD risk factors. Both definitions similarly classified âˆ¼94% of the patients as either having or not having MetS. Discussion: Both definitions can be used interchangeably to diagnose MetS. However, the clinical usefulness of MetS is debatable given the very high prevalence of this condition in T2DM.

ACCESSION #

33044662

Related Articles

The authors reflect on the use of glucose lowering to control macrovascular disease in type 2 diabetes. They suggest that research conducted on patients with type 2 diabetes suggests that glycemic control is associated with the prevention of microvascular complications. They argue that any...

Adiponectin, predominantly synthesized in the adipose tissue, seems to have substantial anti-inflammatory properties and to be a major modulator of insulin resistance and dyslipidemia, mechanisms that are associated with an increased atherosclerotic risk in diabetic patients. However, it is...

Background: Abdominal obesity is a more important risk factor than overall obesity in predicting the development of type 2 diabetes and cardiovascular disease. From a preventive and public health point of view it is crucial that risk factors are identified at an early stage, in order to change...

Aims/hypothesis: Familial partial lipodystrophy (FPLD) and obesity are both associated with increased risks of type 2 diabetes and cardiovascular disease. Although adipokines have been implicated, few data exist in subjects with FPLD; therefore we investigated a family with FPLD due to a lamin...

Background: Glucose intolerance is a major health problem and is associated with increased risk of progression to type 2 diabetes mellitus and cardiovascular disease. However, whether glucose intolerance is related to impaired myocardial perfusion is not known. The purpose of the present study...

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. The presentation is diverse. There is no single, unified definition of PCOS, no single diagnostic test and no consensus on the diagnostic criteria. Currently, PCOS is most commonly defined by the...

This article reports on a study conducted to examine the efficacy of atorvastatin in preventing cardiovascular events or death in patients with type 2 diabetes receiving hemodialysis. 1255 patients 18 to 80 years of age with type 2 diabetes who had been receiving maintenance hemodialysis for...

Background: Although there is a growing body of evidence showing that patients with type 2 diabetes mellitus (T2DM) have poor glycemic control in general, it is not clear whether T2DM patients with pre-existing cardiovascular diseases (CVD) are more or less likely to have good glycemic control...

Background: We describe the design and present the results of the first year of a population-based study of screening for type 2 diabetes in individuals at high risk of developing the disease. High risk is defined as having abdominal obesity. Methods: Between 2006 and 2007, 79,142 inhabitants of...